Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Obstetrics/Gynecology (Women’s Health) | Family Medicine
Pregnancy Clinical Trials
A listing of Pregnancy medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : University of Alabama Birmingham Hospital- UAB
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Arizona
Tucson : University of Arizona - University Medical Center
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
California
San Diego : West Coast OB/GYN
Comparison of Aneuploidy Risk Evaluations
San Diego : Research Site
Organization of Teratology Information Services (OTIS) Autoimmune Diseases in Pregnancy Project
San Jose : Ariosa Diagnostics
Development of a Non-invasive Prenatal Test
Florida
Lake Worth : Altus Research
Drug to Prevent Pre-term Labor
View More »
Daytona Beach :
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
Gainesville : University of Florida College of Medicine
Electrohysterogram-based Sensor for Non-Invasive Contraction Monitoring With Improved Reliability
Miami :
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
Port Saint Lucie :
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
West Palm Beach :
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
Georgia
Atlanta : AD Williams Laboratory
Comparison of Aneuploidy Risk Evaluations
Atlanta : Emory University School of Medicine
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Illinois
Chicago : Prentice Women's Hospital
Comparison of Aneuploidy Risk Evaluations
Chicago : Northwestern Memorial Hospital-Northwestern University Feinberg School of Medicine
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Kentucky
Massachusetts
Boston : Brigham & Women's Hospital - Harvard
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Michigan
Ann Arbor : i3 Drug Safety
VIBATIV Pregnancy Registry
Detroit : Henry Ford Hospital
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Royal Oak : William Beaumont Hospital
Comparison of Aneuploidy Risk Evaluations
Minnesota
Minneapolis : University of Minnesota
Comparison of Aneuploidy Risk Evaluations
St. Paul : Minnesota Epilepsy Group
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Missouri
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Pregnant women are needed for a research study on sleep apnea.
View More »
St. Louis : Washington University
Comparison of Aneuploidy Risk Evaluations
Nevada
Las Vegas : Desert Perinatal Associates
Comparison of Aneuploidy Risk Evaluations
New Jersey
New York
Great Neck : Biomedical Research Alliance of New York
Women with Epilepsy: Pregnancy Outcomes and Deliveries
Great Neck : Biomedical Research Alliance of New York
Women with Epilepsy: Pregnancy Outcomes and Deliveries
New York : Biomedical Research Alliance of New York
Healthy Volunteers: Pregnancy Outcomes and Deliveries
New York : Biomedical Research Alliance of New York
Women with Epilepsy: Pregnancy Outcomes and Deliveries
View More »
Bronx :
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
Bronx : Jacobi Medical Center
Comparison of Aneuploidy Risk Evaluations
Manhasset : Northshore University Hospital
Comparison of Aneuploidy Risk Evaluations
Manhasset : North Shore Jewish Medical Center
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Mineola : Winthrop University Hospital
Comparison of Aneuploidy Risk Evaluations
New Hyde Park : Long Island Jewish Medical Center
Comparison of Aneuploidy Risk Evaluations
New York : Mount Sinai Medical Center
Comparison of Aneuploidy Risk Evaluations
New York : Columbia University Medical Center/NY Presbyterian Hospital
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
New York : New York University School of Medicine
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
North Carolina
Chapel Hill :
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
Raleigh : Lyndhurst Clinical Research
Comparison of Aneuploidy Risk Evaluations
Wilmington : MotHER Registry Coordinating Center
An Observational Study Of Pregnancy And Pregnancy Outcomes In Women With Breast Cancer Treated With Herceptin Or Perjeta In Combination With Herceptin During Pregnancy Or Within 6 Months Prior To Conception (MotHER)
Wilmington : GSK Investigational Site
Belimumab (BENLYSTA®) Pregnancy Registry
Wilmington : The Cymbalta Pregnancy Registry Call Center
The Cymbalta Pregnancy Registry
View More »
Winston Salem : Wake Forest Baptist Health-Wake Forest University School of Medicine
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Winston-Salem : Lyndhurst Clinical Research
Comparison of Aneuploidy Risk Evaluations
North Dakota
Bismarck : St. Alexius Medical Center
A study of an investigational drug for pregnant women who have previously had a preterm birth (when a baby is born before 37 weeks of pregnancy ).
Ohio
Cincinnati : University of Cincinnati UC Health University Hospital
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Cleveland : Maternal Fetal Medicine
Comparison of Aneuploidy Risk Evaluations
Mayfield Heights : MacDonald Clinical Research Unit
Comparison of Aneuploidy Risk Evaluations
Pennsylvania
South Carolina
Tennessee
Jackson : Jackson Clinic
Comparison of Aneuploidy Risk Evaluations
Texas
Dallas : Practice Research Organization
Comparison of Aneuploidy Risk Evaluations
Houston : Fertility Specialists of Houston
Enhanced Assisted Reproductive Technology Pregnancy Rate by Prostacyclin Analog (Iloprost)
Virginia
Arlington : Millennium Clinical Trials, L.L.C.
Clinical Research Study for Birth Control
View More »
Norfolk : Eastern Virginia Medical School
Comparison of Aneuploidy Risk Evaluations
Norfolk : The Group for Women
Comparison of Aneuploidy Risk Evaluations
West Virginia
Australia
Melbourne : Monash Alfred Pyschiatry Research Centre, Alfred Hospital
The National Register of Antipsychotic Medication in Pregnancy (NRAMP)
Belgium
Brussels : Centre for Reproductive Medicine, UZ Brussel
Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)
Canada
Montreal : OVO Prénatal
Detecting Early Onset Pre-eclampsia and Use of Placental Growth Factor (PlGF) for Marker of Trisomy 21
Toronto : The Toronto Center for Advanced Reproductive Technology
The Effect of Co Enzyme Q10 Together With Fertility Drugs on Pregnancy Outcome of in Vitro Fertilization
Toronto : Mount Sinai Hospital
The Safety of Proctofoam-HC in the Third Trimester of Pregnancy
Toronto : The Hospital for Sick Children
The Safety of Proctofoam-HC in the Third Trimester of Pregnancy
Finland
Helsinki : Div. of Nephrologia, Helsenky, University Hospital
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Jakobstad : Pietarsaari Hospital
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Kajaaha : Kainuu Hospital
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
France
Lille :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Soissons :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Suresnes :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Germany
Alsfeld :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Alzey :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Bad Nauheim :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Bad Wildungen :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Bayreuth :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
View More »
Berlin :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Bochum : Research Site
Fampridine Pregnancy Exposure Registry
Darmstadt :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Essen :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Gutersloh :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Hagenow :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Hamm :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Herne :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Herzberg :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Homberg :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Hurth-Hermulheim :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Kaiserslautern :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Koln :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Leverkusen :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Ludwigslust :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Luebeck :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Magdeburg :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Mayen :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Mettmann :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Munchen :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Potsdam :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Quedlinburg :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Saarlouis :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Solingen :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Weisbaden :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Ireland
Galway :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Israel
Haifa : bnai-Zion Medical center
Determination of Labor Progression Patterns Using Non-invasive, Ultrasound Based, Multiple Parameters
Kfar Saba : Meir Medical Center
Measuring Uterine Electrical Activity Throughout Pregnancy and Labor Measuring Uterine Electrical Activity Throughout Pregnancy and Labor
Italy
Ancona : U.O. Nefrologia e Dialisi, Azienda Ospeadaliero-Universitaria Ospedali Riuniti
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Anzio : Ospedali Riuniti Anzio-Nettuno, Nefrologia e dialisi ASL RMH
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Catania : Azienda ospedialiera per l'Emergenza Cannizzaro - Divisione di Nefrologia, Dialisi e Trapianto
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Chieri : TO 5 - SC Nefrologia 3 Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Milano : Ospadle Niguarda Ca Granda - U.O. Nefrologia e Dialisi e Terapi Medica del Trapianto Renale
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
View More »
Naples : Dipartimento do Patologia Sistematica
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Napoli : Dialysis
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Napoli : Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli - U.O. S.C. Nefrologia ed Emodialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Nocera : ASL SA 1 P.O. Umberto 1 - U.O.C. di Nefrologia e Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Nola : Ospedale Santa maria Della Pieta U.O.C. di Nefrologia e Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Pavia : Lavoro e Delia Riabilitazione, Divisione Nefrologia ed Emodialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Roma : Fondazinoe PTV Ploiclinico Tor Vergata U.O.S.D. Nefrologia e Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
S. Angelo dei Lombardi : Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Santa Maria : Presidio Ospedaliero S. Guiseppe e Melorio ausl CE/2 S-U.O. Nefrologia e Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Soverato : Presidio Ospedaliero de Soverato Servizio Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Torino : Complessa Nefrologia e Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Torino : OSPEDALE MARTINI - SC, Nefrologia e Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Zingonia-Oslo Sotto : Bergamaschi, U.O. Nefrologia e Dialisi
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Portugal
Canelas : Caledial
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Puerto Rico
San Juan Pr :
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
Spain
Alicante : Universitario de Alicante
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Barcelona : Hospital de Barcelona
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Barcelona : Fundacio Puigvert
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Benalmadena : Xanit Hospital Internacional
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Fuenlabrada : Fuenlabrada
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
View More »
Terrassa : Hospital Mutua de Terrassa
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Xativa : Hospital Lluis Alcanyis
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Sweden
Linkoping : Linkopings Universitetssjukhus
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Stockholm : Karolinska University Hospital
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
Thailand
Bangkok : Bhumibol Adulyadej Hospital
Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand
Chantaburi : Prapokklao Hospital
Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand
Chiang Rai : Chiangrai Prachanukroh Hospital
Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand
Chonburi : Chonburi Regional Hospital
Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand
Phayao : Phayao Provincial Hospital
Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand
United Kingdom
London :
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO 11)
